StockData
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT) stock

VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)

Close on Nov 17, 2026Market cap $68.37MP/E –Yield –

vTv Therapeutics total assets

Total assets on the balance sheet at the end of each period.

vTv Therapeutics's total assets was $87.59M at Jun 30, 2026. For fiscal 2025 it was $89.90M, up 134.9% from the year before. Over ten years it grew -0.2% a year on average. The highest annual figure on record is $91.53M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$89.90M+134.9%
FY2024Dec 31, 2024$38.27M+247.3%
FY2023Dec 31, 2023$11.02M-66.9%
FY2022Dec 31, 2022$33.24M+30.5%
FY2021Dec 31, 2021$25.47M+72.2%
FY2020Dec 31, 2020$14.79M+59.6%
FY2019Dec 31, 2019$9.27M+8.3%
FY2018Dec 31, 2018$8.56M-69.3%
FY2017Dec 31, 2017$27.92M-48.8%
FY2016Dec 31, 2016$54.50M-40.5%
FY2015Dec 31, 2015$91.53M+606.8%
FY2014Dec 31, 2014$12.95M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$87.59M+231.2%
Q1 FY2026Mar 31, 2026$98.81M+208.5%
Q4 FY2025Dec 31, 2025$89.90M+134.9%
Q3 FY2025Sep 30, 2025$99.49M+130.5%
Q2 FY2025Jun 30, 2025$26.45M-43.1%
Q1 FY2025Mar 31, 2025$32.03M-40.9%
Q4 FY2024Dec 31, 2024$38.27M+247.3%
Q3 FY2024Sep 30, 2024$43.16M+189.2%
Q2 FY2024Jun 30, 2024$46.46M+107.2%
Q1 FY2024Mar 31, 2024$54.18M+88.0%
Q4 FY2023Dec 31, 2023$11.02M-66.9%
Q3 FY2023Sep 30, 2023$14.92M-58.0%
Q2 FY2023Jun 30, 2023$22.43M-39.4%
Q1 FY2023Mar 31, 2023$28.83M+42.8%
Q4 FY2022Dec 31, 2022$33.24M+30.5%
Q3 FY2022Sep 30, 2022$35.52M+13.0%
Q2 FY2022Jun 30, 2022$36.99M+70.8%
Q1 FY2022Mar 31, 2022$20.19M+20.5%
Q4 FY2021Dec 31, 2021$25.47M+72.2%
Q3 FY2021Sep 30, 2021$31.43M+346.1%
Q2 FY2021Jun 30, 2021$21.66M+103.8%
Q1 FY2021Mar 31, 2021$16.75M+126.7%
Q4 FY2020Dec 31, 2020$14.79M+59.6%
Q3 FY2020Sep 30, 2020$7.05M-22.8%
Q2 FY2020Jun 30, 2020$10.63M+17.2%
Q1 FY2020Mar 31, 2020$7.39M-31.2%
Q4 FY2019Dec 31, 2019$9.27M+8.3%
Q3 FY2019Sep 30, 2019$9.12M-17.7%
Q2 FY2019Jun 30, 2019$9.07M-19.2%
Q1 FY2019Mar 31, 2019$10.74M-27.1%
Q4 FY2018Dec 31, 2018$8.56M-69.3%
Q3 FY2018Sep 30, 2018$11.09M-53.9%
Q2 FY2018Jun 30, 2018$11.23M-68.6%
Q1 FY2018Mar 31, 2018$14.73M-69.5%
Q4 FY2017Dec 31, 2017$27.92M-48.8%
Q3 FY2017Sep 30, 2017$24.06M-56.0%
Q2 FY2017Jun 30, 2017$35.78M–
Q1 FY2017Mar 31, 2017$48.33M–
Q4 FY2016Dec 31, 2016$54.50M–
Q3 FY2016Sep 30, 2016$54.72M–

More vTv Therapeutics figures

See a number that looks wrong?